Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2018, Vol. 12 ›› Issue (11): 609-613. doi: 10.3877/cma.j.issn.1674-0785.2018.11.004

Special Issue:

• Clinical Research • Previous Articles     Next Articles

MiRNA-224-5p regulates apoptosis of papillary thyroid carcinoma cells via the transforming growth factor beta/Smad4 signaling pathway

Nan Ma1, Rong Xu2, Pengcheng Su1,()   

  1. 1. Department of Mammary and Thyroidology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China
    2. Department of Oncology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China
  • Received:2018-03-11 Online:2018-06-01 Published:2018-06-01
  • Contact: Pengcheng Su
  • About author:
    Corresponding author: Su Pengcheng, Email:

Abstract:

Objective

To explore the role of miRNA-224-5p in the apoptosis of papillary thyroid carcinoma cells and the underlying mechanism.

Methods

The expression of miRNA-224-5p in 60 cases of papillary thyroid carcinoma and adjacent tissue was detected by RT-PCR. Human papillary thyroid carcinoma GLAG-66 cells were cultured, miRNA-224-5p and miRNA-224-5p inhibitor were transfected into cells, and the expression of miRNA-224-5p was detected by RT-PCR. Cell apoptosis was detected by flow cytometry 48 h later. The expression of Bcl-2, Bax, Cleaved-Caspase3, TGF-β1, and Smad4 proteins was detected by Western blot.

Results

The expression of miRNA-224-5p in papillary thyroid carcinoma tissue was significantly higher than that in paracancerous tissue [(4.175±0.523) vs (1.236±0.236), t=9.675, P=0.001], and the expression of miRNA-224-5p was significantly lower in the miRNA-224-5p inhibitor group than in the miRNA-224-5p group [(0.381±0.078) vs (1.000±0.023), t=19.785, P<0.001)]. Compared with the miRNA-224-5p group, the apoptosis rate significantly increased in the miRNA-224-5p inhibitor group [(18.66%±0.98%) vs (3.78%±0.36%), t=17.561, P<0.001]. Compared with the miRNA-224-5p group, the expression of Bcl-2, TGF-β1 and Smad4 in the miRNA-224-5p inhibitor group was significantly decreased [(0.197±0.008) vs (0.278±0.013), t=8.259, P=0.001; (0.117±0.013) vs (0.227±0.012), t=13.269, P<0.001; (0.268±0.012) vs (0.439±0.016), t=9.897, P=0.001], and the expression of Bax and Cleaved-Caspase3 protein was significantly increased [(0.286±0.011) vs (0.159±0.009), t=12.569, P<0.001; (0.128±0.009) vs (0.083±0.010), t=7.693, P=0.002].

Conclusion

MiRNA-224-5p is highly expressed in papillary thyroid carcinoma, and down-regulation of miRNA-224-5p promotes cell apoptosis via mechanisms possibly related to regulation of the TGF-β/Smad4 signaling pathway.

Key words: MiRNA-224-5p, Papillary thyroid carcinoma, TGF-β/Smad4 signaling pathway, Apoptosis

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd